Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Since the Covid-19 outbreak first emerged into the public consciousness in mid-January this year, the pharma industry has been working hard to repurpose existing anti-viral drugs and fast-track vaccine development for this novel coronavirus.
During an International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) briefing, the organisation’s director-general Thomas Cueni noted how far the pharma industry had come in a few short months, stating how much the industry benefitted from the Chinese authorities’ move to quickly share the genetic sequence of Covid-19.